Cargando…

Fasting and stimulated glucagon-like peptide-1 exhibit a compensatory adaptive response in diabetes and pre-diabetes states: A multi-ethnic comparative study

BACKGROUND: Impaired secretion of glucagon-like peptide-1 (GLP-1) among Caucasians contributes to reduced incretin effect in type 2 diabetes mellitus (T2DM) patients. However, studies emanating from East Asia suggested preserved GLP-1 levels in pre-diabetes (pre-DM) and T2DM. We aimed to resolve the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Shiau Chin, Sukor, Norlela, Robert, Sarah Anne, Ng, Kim Fong, Kamaruddin, Nor Azmi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501699/ https://www.ncbi.nlm.nih.gov/pubmed/36157456 http://dx.doi.org/10.3389/fendo.2022.961432

Ejemplares similares

Endogenous GLP-1 levels play an important role in determining the efficacy of DPP-IV Inhibitors in both prediabetes and type 2 diabetes
por: Chong, Shiau Chin, et al.
Publicado: (2022)

Case Report: High-Calorie Glucose Infusion and Tight Glycemic Control in Ameliorating Refractory Acidosis of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis
por: Wan Azman, Siti Sanaa, et al.
Publicado: (2022)

Editorial: Expanding spectrum of primary aldosteronism: exploring new grounds
por: Sukor, Norlela, et al.
Publicado: (2023)

Prevalence and Histopathological Characteristics of KCNJ5 Mutant Aldosterone-Producing Adenomas in a Multi-Ethnic Malaysian Cohort
por: Mohideen, Syahirah Kaja, et al.
Publicado: (2019)

Profiles and Factors Associated with Poor Glycemic Control Among Inpatients with Diabetes Mellitus Type 2 as a Primary Diagnosis in a Teaching Hospital
por: Ismail, Aniza, et al.
Publicado: (2016)

Study protocol to develop a core outcome set for thyroid dysfunction to bridge the unmet needs of patient-centred care
por: Ooi, Cheow Peng, et al.
Publicado: (2021)

A Case of Retroperitoneal Liposarcoma Mimicking an Adrenocortical Carcinoma
por: Kang, Waye, et al.
Publicado: (2019)

Primary aldosteronism and obstructive sleep apnea: What do we know thus far?
por: Loh, Huai Heng, et al.
Publicado: (2022)

Editorial: Adrenal related hypertension: from bench to bedside
por: Sukor, Norlela, et al.
Publicado: (2023)

SUN-711 Association of Single Nucleotide Polymorphisms of CYP11B2, CYP11B1 and CYP17A1 with Primary Aldosteronism in a Multi-Ethnic Malaysian Cohort
por: Azam, Afifah, et al.
Publicado: (2020)

Fluconazole as a Safe and Effective Alternative to Ketoconazole in Controlling Hypercortisolism of Recurrent Cushing’s Disease: A Case Report
por: Teng Chai, Shu, et al.
Publicado: (2018)

Case Report: Severe Hypernatremia From Ingestion of One's Own Urine
por: Kang, Waye Hann, et al.
Publicado: (2022)

Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes
por: Jia, Yunbo, et al.
Publicado: (2022)

MON-318 Selective ACTH Sampling in Localizing Source of ACTH in Von Hippel Lindau Disease with Pancreatic Neuroendocrine Tumour and Renal Cell Carcinoma
por: Singarayar, Carolina, et al.
Publicado: (2019)

MON-LB129 A Pilot Genome Wide Association Study (GWAS) on Primary Aldosteronism Patients in a Multi-Ethnic Malaysian Cohort
por: Azizan, Elena AB, et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis
por: Wong, Chloe, et al.
Publicado: (2021)

Glycemic Control among Pregnant Diabetic Women on Insulin Who Fasted During Ramadan
por: Ismail, Nor Azlin Mohamed, et al.
Publicado: (2011)

Estrogen Receptors in Nonfunctioning Pituitary Neuroendocrine Tumors: Review on Expression and Gonadotroph Functions
por: Haydar Ali Tajuddin, Amalina, et al.
Publicado: (2020)

It Is Time to Consider Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes in Youth
por: Oberle, Megan M., et al.
Publicado: (2019)

Fasting Glucagon Level in Type 2 Diabetes and Impaired Glucose Tolerance and Its Association With Diabetes-Associated Clinical Parameters: A Study From Karachi, Pakistan
por: Abbas, Eraj, et al.
Publicado: (2021)

Endocrine Regulation of Compensatory Growth in Fish
por: Won, Eugene T., et al.
Publicado: (2013)

Discordance between Fasting Plasma Glucose (FPG) and HbA1c in Diagnosing Diabetes and Pre-diabetes in The Malaysian Cohort
por: Abdul Murad, Nor Azian, et al.
Publicado: (2021)

Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
por: Wang, Ying, et al.
Publicado: (2021)

Safety of sodium–glucose cotransporter 2 inhibitors in Asian type 2 diabetes populations
por: Davidson, Jaime A, et al.
Publicado: (2022)

Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
por: Chang, Li-Hsin, et al.
Publicado: (2022)

Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus
por: Iwamoto, Yuichiro, et al.
Publicado: (2022)

Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides
por: Sekar, Revathi, et al.
Publicado: (2017)

Defining Disease Progression and Drug Durability in Type 2 Diabetes Mellitus
por: Kalra, Sanjay, et al.
Publicado: (2019)

Corrigendum: Central Control of Feeding Behavior by the Secretin, PACAP, and Glucagon Family of Peptides
por: Sekar, Revathi, et al.
Publicado: (2018)

Decreased expression of Glucagon-like peptide-1 receptor and Sodium-glucose co-transporter 2 in patients with proliferative diabetic retinopathy
por: Chen, Hui, et al.
Publicado: (2022)

Identification of Novel Biomarkers for Pre-diabetic Diagnosis Using a Combinational Approach
por: Yang, Meng-Ting, et al.
Publicado: (2021)

Are the determinants of the progression to type 2 diabetes and regression to normoglycemia in the populations with pre-diabetes the same?
por: Alizadeh, Zeinab, et al.
Publicado: (2022)

Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
por: Antonellis, Patrick Joseph, et al.
Publicado: (2016)

Plasticity in the Glucagon Interactome Reveals Novel Proteins That Regulate Glucagon Secretion in α-TC1-6 Cells
por: Asadi, Farzad, et al.
Publicado: (2019)

Mathematical Model of Glucagon Kinetics for the Assessment of Insulin-Mediated Glucagon Inhibition During an Oral Glucose Tolerance Test
por: Morettini, Micaela, et al.
Publicado: (2021)

Understanding Pre-Type 1 Diabetes: The Key to Prevention
por: Jacobsen, Laura M., et al.
Publicado: (2018)

Methylglyoxal products in pre-symptomatic type 1 diabetes
por: Shuck, Sarah C., et al.
Publicado: (2023)

PSUN14 Elucidating Effect of Modulating Aldosterone Synthesis on Cell Fate in Human Adrenal Cells
por: Long, Kha Chin, et al.
Publicado: (2022)

Effect of dipeptidyl peptidase-4 inhibitors on postprandial glucagon level in patients with type 2 diabetes mellitus: A systemic review and meta-analysis
por: Chai, Shangyu, et al.
Publicado: (2022)

Prevalence and Risk Factors of Sensory Symptoms in Diabetes Patients in Taiwan
por: Tseng, Chin-Hsiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vvn8p9uiob4v46sa7jvq64t8ur